Athira Pharma

BiotechnologySeries BBothell, USathira.com

Latest round

Series B

Last raised

May 2020

Total raised

$100M

Investors

19

About Athira Pharma

Based in Washington, US, and founded in 2011, Athira Pharma, Inc. operates as a biopharmaceutical company dedicated to developing novel small molecule therapeutics aimed at treating neurodegenerative diseases. In September 2020, Athira Pharma, Inc. The company targets the neurotrophic hepatocyte growth factor (HGF) system to promote neuronal regeneration, provide neuroprotection, and potentially modify the progression of diseases such as Alzheimer’s, Parkinson’s, and ALS. Athira's product pipeline includes several promising candidates, with Fosgonimeton (ATH-1017) being the most advanced. These small molecules are designed to enhance the HGF signaling system, which has shown potential in preclinical studies to reduce inflammation, slow neurodegeneration, and offer neuroprotection.

Who invested in Athira Pharma

19 investors across 3 rounds

See all investors in Athira Pharma

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    May 29, 2020

    Amount

    $89M

    Investors

    Locked

  2. Series A

    Apr 13, 2017

    Amount

    $1.4M

    Investors

    Locked

  3. Series A

    Feb 11, 2016

    Amount

    $10M

    Investors

    Locked

Questions about Athira Pharma

Who invested in Athira Pharma?

Athira Pharma has 19 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Athira Pharma raised?

Athira Pharma has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Athira Pharma last raise money?

Athira Pharma's most recent round on record is a Series B, in May 2020.

What does Athira Pharma do?

Based in Washington, US, and founded in 2011, Athira Pharma, Inc.

Where is Athira Pharma headquartered?

Athira Pharma is headquartered in Bothell, US.

Which VCs invest in companies like Athira Pharma?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Athira Pharma's stage. Their profiles are linked below.

Raising like Athira Pharma? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.